{"title":"GENDER DIFFERENCES IN COVID-19 VACCINATION IN UKRAINE","authors":"T. Mamontova","doi":"10.26724/2079-8334-2023-1-83-130-134","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic is among the greatest challenges for the worldwide. Vaccine development is an effective weapon against pandemic development. But there is a paucity of data of COVID-19 vaccine data by sex/gender in Ukraine. The purpose of the study was to assess diversity in COVID-19 vaccination among gender groups of Ukrainian population. A retrospective-archive study was conducted in Ukraine from 24 February 2021 to 16 January 2022. The obtained data showed in trends gender differences in COVID-19 vaccination status. Women preferred vaccination with Pfizer/Biontech and AstraZeneca vaccines more often than men. Significantly higher level of weekly cases among persons who received two doses than one dose of Pfizer/BioNTech vaccine with as among males (p<0.05), as females (p<0.05). These findings support idea that a gendered lens should also be applied when designing COVID-19 vaccination campaign that can help to maximize benefits and minimize adverse events.","PeriodicalId":23771,"journal":{"name":"World of Medicine and Biology","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World of Medicine and Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26724/2079-8334-2023-1-83-130-134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
The COVID-19 pandemic is among the greatest challenges for the worldwide. Vaccine development is an effective weapon against pandemic development. But there is a paucity of data of COVID-19 vaccine data by sex/gender in Ukraine. The purpose of the study was to assess diversity in COVID-19 vaccination among gender groups of Ukrainian population. A retrospective-archive study was conducted in Ukraine from 24 February 2021 to 16 January 2022. The obtained data showed in trends gender differences in COVID-19 vaccination status. Women preferred vaccination with Pfizer/Biontech and AstraZeneca vaccines more often than men. Significantly higher level of weekly cases among persons who received two doses than one dose of Pfizer/BioNTech vaccine with as among males (p<0.05), as females (p<0.05). These findings support idea that a gendered lens should also be applied when designing COVID-19 vaccination campaign that can help to maximize benefits and minimize adverse events.